logo
ResearchBunny Logo
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus

Medicine and Health

Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus

A. A. Weil, K. G. Luiten, et al.

This study, conducted by a team of researchers including Ana A Weil and Kyle G Luiten, reveals how genomic surveillance on a university campus tracked the rapid surge of the SARS-CoV-2 Omicron variant, highlighting crucial differences in infection dynamics compared to Delta variants. Discover the vital role this research plays in shaping public health responses amidst the pandemic.... show more
Citation Metrics
Citations
30
Influential Citations
1
Reference Count
47
Citation by Year

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding of the subject.

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
Medicine and Health

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration

H. Ma, X. Zhang, et al.

Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron
Medicine and Health

Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron

H. Liu, C. I. Kaku, et al.

SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses
Medicine and Health

SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses

M. Yousif, S. Rachida, et al.

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
Medicine and Health

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

A. L. Koen, A. Izu, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny